The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 02, 2021
Filed:
Aug. 30, 2018
Applicants:
The Trustees of the University of Pennsylvania, Philadelphia, PA (US);
Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);
Inventors:
David Weiner, Merion, PA (US);
Daniel Villarreal, San Diego, CA (US);
Matthew Morrow, Bala Cynwyd, PA (US);
Jian Yan, Wallingford, PA (US);
Assignees:
The Trustees of the University of Pennsylvania, Philadelphia, PA (US);
Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); A61K 38/20 (2006.01); C12N 15/63 (2006.01); A61K 38/16 (2006.01); C07K 14/54 (2006.01); A61K 39/015 (2006.01); A61K 39/04 (2006.01); A61K 39/12 (2006.01); C12N 15/82 (2006.01); A61K 39/21 (2006.01); C12N 7/00 (2006.01); A61K 38/00 (2006.01); C07K 14/025 (2006.01); C07K 14/35 (2006.01); C07K 14/16 (2006.01); C07K 14/005 (2006.01); C07K 14/445 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 38/162 (2013.01); A61K 38/164 (2013.01); A61K 38/20 (2013.01); A61K 39/015 (2013.01); A61K 39/04 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); C07K 14/54 (2013.01); C12N 7/00 (2013.01); C12N 15/63 (2013.01); C12N 15/8206 (2013.01); A61K 39/0011 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55527 (2013.01); A61K 2039/57 (2013.01); A61K 2039/572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/585 (2013.01); C07K 14/005 (2013.01); C07K 14/025 (2013.01); C07K 14/16 (2013.01); C07K 14/35 (2013.01); C07K 14/445 (2013.01); C12N 15/09 (2013.01); C12N 2710/20034 (2013.01); C12N 2740/16034 (2013.01); C12N 2760/10034 (2013.01); Y02A 50/30 (2018.01);
Abstract
Disclosed herein is a vaccine comprising an antigen and IL-33. Also disclosed herein is a method for increasing an immune response in a subject in need thereof. Further disclosed herein is a method for treating cancer in a subject in need thereof. The methods may comprise administering the vaccine to the subject.